EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
CHEBI:31762 - lanperisone hydrochloride
| Formula | C15H18F3NO.HCl |
| Net Charge | 0 |
| Average Mass | 321.770 |
| Monoisotopic Mass | 321.11073 |
| SMILES | C[C@H](CN1CCCC1)C(=O)c1ccc(C(F)(F)F)cc1.Cl |
| InChI | InChI=1S/C15H18F3NO.ClH/c1-11(10-19-8-2-3-9-19)14(20)12-4-6-13(7-5-12)15(16,17)18;/h4-7,11H,2-3,8-10H2,1H3;1H/t11-;/m1./s1 |
| InChIKey | PHBZFPOOJUGYCR-RFVHGSKJSA-N |
| Roles Classification |
|---|
| Biological Roles: | calcium channel blocker One of a class of drugs that acts by selective inhibition of calcium influx through cell membranes or on the release and binding of calcium in intracellular pools. ferroptosis inducer Any substance that induces or promotes ferroptosis (a type of programmed cell death dependent on iron and characterized by the accumulation of lipid peroxides) in organisms. voltage-gated sodium channel blocker Any sodium channel blocker that interferes with the activity of voltage-gated sodium channels. |
| Applications: | antineoplastic agent A substance that inhibits or prevents the proliferation of neoplasms. muscle relaxant A drug used to produce muscle relaxation (excepting neuromuscular blocking agents). Its primary clinical and therapeutic use is the treatment of muscle spasm and immobility associated with strains, sprains, and injuries of the back and, to a lesser degree, injuries to the neck. Also used for the treatment of a variety of clinical conditions that have in common only the presence of skeletal muscle hyperactivity, for example, the muscle spasms that can occur in multiple sclerosis. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| lanperisone hydrochloride (CHEBI:31762) has part lanperisone(1+) (CHEBI:176341) |
| lanperisone hydrochloride (CHEBI:31762) has role antineoplastic agent (CHEBI:35610) |
| lanperisone hydrochloride (CHEBI:31762) has role calcium channel blocker (CHEBI:38215) |
| lanperisone hydrochloride (CHEBI:31762) has role ferroptosis inducer (CHEBI:173085) |
| lanperisone hydrochloride (CHEBI:31762) has role muscle relaxant (CHEBI:51371) |
| lanperisone hydrochloride (CHEBI:31762) has role voltage-gated sodium channel blocker (CHEBI:38634) |
| lanperisone hydrochloride (CHEBI:31762) is a hydrochloride (CHEBI:36807) |
| IUPAC Name |
|---|
| (2R)-2-methyl-3-(pyrrolidin-1-yl)-1-[4-(trifluoromethyl)phenyl]propan-1-one hydrochloride |
| Synonyms | Source |
|---|---|
| 1-{(2R)-2-methyl-3-oxo-3-[4-(trifluoromethyl)phenyl]propyl}pyrrolidinium chloride | IUPAC |
| (−)-(R)-2-methyl-3-(1-pyrrolidinyl)-4'-trifluoromethylpropiophenone monohydrochloride | ChEBI |
| lanperisone HCl | ChEBI |
| Lanperisone hydrochloride | KEGG DRUG |
| lanperisone monohydrochloride | ChEBI |
| NK 433 | KEGG DRUG |
| Registry Numbers | Sources |
|---|---|
| CAS:116287-13-9 | ChemIDplus |
| Citations |
|---|